This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 fixed-price delivery order is for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $64,352,514.80 IDC with the Department of Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The firm-fixed-price delivery order has a ceiling value of $476,414.19 and a completion date of April 30, 2024. The contract is not set aside for a specific business designation. Teva Pharmaceuticals USA, Inc. is a leading global pharmaceutical company that...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger contract vehicle, and Teva has received multiple prior delivery orders for this vaccine to support military immunization programs. Teva also holds several significant Indefinite...
This federal contract award, SPE2DP20D0002|SPE2DP24F3170, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 firm-fixed-price delivery order is for the supply of Adenovirus Type 4 A vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) that establishes Teva as the national prime vendor to provide critical pharmaceutical products,...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. has a history of providing critical drug products, such as vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $476,414.19, is for the supply of Adenovirus Type 4 vaccine, a critical product that supports military immunization programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Teva and the Department of Veterans Affairs (VA) National Acquisition Center,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 firm fixed-price delivery order is for the supply of Adenovirus Type 4 vaccines, supporting military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global Teva Pharmaceutical Industries Ltd. and has numerous prime contract awards with federal agencies, including...
This federal contract award, valued at $990,941.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the supply of Adenovirus Type 4 vaccine, a critical medical product that supports military immunization programs. The contract is a firm-fixed-price arrangement with a period of performance through March 25, 2025. Teva Pharmaceuticals USA, Inc....
This is a $476,414.19 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Adenovirus Type 4 vaccine, a critical product for military immunization programs. The $158,804.73 firm-fixed-price contract has a period of performance through March 26, 2024. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts and delivery orders from...